LivaNova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions in Generalized Tonic-Clonic Seizures in People With Drug-Resistant Epilepsy

THOMSON REUTERS
05 Jun

LivaNova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions in Generalized Tonic-Clonic Seizures in People With Drug-Resistant Epilepsy

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10